부가기능
Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infaretion Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study/
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.